Adipokines Linking Obesity with Colorectal Cancer Risk in Postmenopausal Women
Authors:
- Gloria Y.F. HoGHGloria Y.F. Ho
- Tao WangTWTao Wang
- Marc J. GunterMGMarc J. Gunter
- Howard D. StricklerHSHoward D. Strickler
- Mary CushmanMCMary Cushman
- Robert C. KaplanRKRobert C. Kaplan
- Sylvia Wassertheil-SmollerSWSylvia Wassertheil-Smoller
- Xiaonan XueXXXiaonan Xue
- Swapnil N. RajpathakSRSwapnil N. Rajpathak
- Rowan T. ChlebowskiRCRowan T. Chlebowski
- Mara Z. VitolinsMVMara Z. Vitolins
- Philipp E. SchererPSPhilipp E. Scherer
- 14 June 2012
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 72 (12) , 3029-3037
Abstract
Mechanistic associations between obesity and colorectal cancer remain unclear. In this study, we investigated whether adipokines are risk factors for colorectal cancer and whether they may mediate its association with obesity. In a case–cohort study nested within the Women's Health Initiative cohort of postmenopausal women, baseline plasma samples from 457 colorectal cancer cases and 841 subcohort subjects were assayed for seven adipokines—adiponectin, leptin, plasminogen activator inhibitor-1 (PAI-1), resistin, hepatocyte growth factor, interleukin-6 (IL-6), and TNF-α. Serum insulin and estradiol values measured previously were also available for data analysis. After adjusting for age, race, smoking, colonoscopy history, and estrogen level, a low level of anti-inflammatory adiponectin and high levels of proinflammatory leptin, PAI-1, and IL-6 were associated with increased colorectal cancer risk, though only leptin remained significant after further adjustment for insulin [HRs comparing extreme quartiles (HRQ4–Q1), 1.84; 95% CI, 1.17–2.90]. Mediation analyses showed that leptin and insulin partially explained the association between waist circumference and colorectal cancer and attenuated it by 25% and 37%, respectively, with insulin being a significant mediator (P = 0.041). Our findings support the conclusion that adipokines involved in inflammation are associated with colorectal cancer risk, but that their effects may be mediated mostly by insulin, with leptin exerting an independent effect. Hyperinsulinemia and hyperleptinemia may therefore partially explain the adiposity association with colorectal cancer in postmenopausal women. Cancer Res; 72(12); 3029–37. ©2012 AACR.Keywords
All Related Versions
This publication has 49 references indexed in Scilit:
- Obesity and Cancer: The Role of Dysfunctional Adipose TissueCancer Epidemiology, Biomarkers & Prevention, 2009
- Postmenopausal Levels of Endogenous Sex Hormones and Risk of Colorectal CancerCancer Epidemiology, Biomarkers & Prevention, 2009
- Reproducibility of serum cytokines and growth factorsCytokine, 2009
- Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal WomenJNCI: Journal of the National Cancer Institute, 2008
- A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial CancerCancer Epidemiology, Biomarkers & Prevention, 2008
- Insulin, Insulin-like Growth Factor-I, Endogenous Estradiol, and Risk of Colorectal Cancer in Postmenopausal WomenCancer Research, 2008
- Adipocytokines: mediators linking adipose tissue, inflammation and immunityNature Reviews Immunology, 2006
- Circulating Levels of Inflammatory Markers and Cancer Risk in the Health Aging and Body Composition CohortCancer Epidemiology, Biomarkers & Prevention, 2005
- Leptin, from fat to inflammation: old questions and new insightsFEBS Letters, 2004
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004